Arcus Biosciences RCUS Business Segments
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Arcus Biosciences break its business down?
- Arcus Biosciences (RCUS) reports royalty expense by product across 2 parts — anti-CD39 and anti-PD-1. Each is extracted from the segment footnotes and tracked over time.
- Where does Arcus Biosciences's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Arcus Biosciences's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
